Four long noncoding RNAs act as biomarkers in lung adenocarcinoma
Zhang Zhihui,
Yang Liu,
Li Yujiang,
Wu Yunfei,
Li Xiang,
Wu Xu
Affiliations
Zhang Zhihui
Department of Thoracic and Cardiovascular Surgery/Huiqiao Medical Center, Nanfang Hospital, Southern Medical University, Jingxi Street, Guangzhou, Guangdong 510515, China
Yang Liu
Department of Radiology, Charité – Universitätsmedizin Berlin, Berlin, Germany
Li Yujiang
Department of Thoracic and Cardiovascular Surgery/Huiqiao Medical Center, Nanfang Hospital, Southern Medical University, Jingxi Street, Guangzhou, Guangdong 510515, China
Wu Yunfei
Department of Thoracic and Cardiovascular Surgery/Huiqiao Medical Center, Nanfang Hospital, Southern Medical University, Jingxi Street, Guangzhou, Guangdong 510515, China
Li Xiang
Department of Emergency Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China
Wu Xu
Department of Thoracic and Cardiovascular Surgery/Huiqiao Medical Center, Nanfang Hospital, Southern Medical University, Jingxi Street, Guangzhou, Guangdong 510515, China
Lung adenocarcinoma (LUAD) is currently one of the most common malignant tumors worldwide. However, there is a lack of long noncoding RNA (lncRNA)-based effective markers for predicting the prognosis of LUAD patients. We identified four lncRNAs that can effectively predict the prognosis of LUAD patients.
